Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TipRanksNov 25 07:46 ET · Ratings

GSK Cancer Therapy Candidate Accepted for FDA Review

MT NewswiresNov 25 07:03 ET

Blenrep Combinations Accepted for Review by the US FDA for the Treatment of Relapsed/refractory Multiple Myeloma

GSK PlcNov 25 00:00 ET

Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC

Seeking AlphaNov 22 21:25 ET

GSK's RSV Vaccine Approved for Japanese Patients in Their 50s

MT NewswiresNov 22 07:05 ET

Arexvy Approval Expanded to Adults Aged 50-59 at Increased Risk of Severe RSV Disease in Japan

GSK PlcNov 22 00:00 ET